Catalyst Wire Dossier Catalyst Wire Dossier

Autologous bone marrow stem cell intravitreal injection

autologous bone marrow-derived stem cells for intravitreal use · Red de Terapia Celular
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous bone marrow stem cell intravitreal injection, covering 2017-03-30 to 2017-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa [Phase 1]

See pricing